Flexible microfluidic devices supported by biodegradable insertion scaffolds for convection-enhanced neural drug delivery

被引:47
作者
Foley, Conor P. [1 ]
Nishimura, Nozomi [2 ]
Neeves, Keith B. [3 ]
Schaffer, Chris B. [2 ]
Olbricht, William L. [1 ,2 ]
机构
[1] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA
[2] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA
[3] Colorado Sch Mines, Dept Chem Engn, Golden, CO 80401 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Convection-enhanced delivery; Flexible neural implant; Microfluidics; Drug delivery; PEGYLATED LIPOSOMAL DOXORUBICIN; RECURRENT MALIGNANT GLIOMA; NEUROTROPHIC FACTOR; GLIOBLASTOMA-MULTIFORME; PRIMATE BRAIN; GROWTH-FACTOR; RAT-BRAIN; DEGRADATION; FABRICATION; TRANSPORT;
D O I
10.1007/s10544-009-9308-6
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Convection enhanced delivery (CED) can improve the spatial distribution of drugs delivered directly to the brain. In CED, drugs are infused locally into tissue through a needle or catheter inserted into brain parenchyma. Transport of the infused material is dominated by convection, which enhances drug penetration into tissue compared with diffusion mediated delivery. We have fabricated and characterized an implantable microfluidic device for chronic convection enhanced delivery protocols. The device consists of a flexible parylene-C microfluidic channel that is supported during its insertion into tissue by a biodegradable poly(DL-lactide-co-glycolide) scaffold. The scaffold is designed to enable tissue penetration and then erode over time, leaving only the flexible channel implanted in the tissue. The device was able to reproducibly inject fluid into neural tissue in acute experiments with final infusate distributions that closely approximate delivery from an ideal point source. This system shows promise as a tool for chronic CED protocols.
引用
收藏
页码:915 / 924
页数:10
相关论文
共 55 条
[1]  
Abramoff M. D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1201/9781420005615.AX4
[2]   Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid polyglycolic acid copolymers [J].
Athanasiou, KA ;
Niederauer, GG ;
Agrawal, CM .
BIOMATERIALS, 1996, 17 (02) :93-102
[3]   CONVECTION-ENHANCED DELIVERY OF MACROMOLECULES IN THE BRAIN [J].
BOBO, RH ;
LASKE, DW ;
AKBASAK, A ;
MORRISON, PF ;
DEDRICK, RL ;
OLDFIELD, EH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2076-2080
[4]   A multichannel neural probe for selective chemical delivery at the cellular level [J].
Chen, JK ;
Wise, KD ;
Hetke, JF ;
Bledsoe, SC .
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 1997, 44 (08) :760-769
[5]   A realistic brain tissue phantom for intraparenchymal infusion studies [J].
Chen, ZJ ;
Gillies, GT ;
Broaddus, WC ;
Prabhu, SS ;
Fillmore, H ;
Mitchell, RM ;
Corwin, FD ;
Fatouros, PP .
JOURNAL OF NEUROSURGERY, 2004, 101 (02) :314-322
[6]   THE EFFECT OF PH ON THE INVITRO DEGRADATION OF POLY(GLYCOLIDE LACTIDE) CO-POLYMER ABSORBABLE SUTURES [J].
CHU, CC .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1982, 16 (02) :117-124
[7]   CONTROLLED DELIVERY SYSTEMS FOR PROTEINS BASED ON POLY(LACTIC GLYCOLIC ACID) MICROSPHERES [J].
COHEN, S ;
YOSHIOKA, T ;
LUCARELLI, M ;
HWANG, LH ;
LANGER, R .
PHARMACEUTICAL RESEARCH, 1991, 8 (06) :713-720
[8]   Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease [J].
Gill, SS ;
Patel, NK ;
Hotton, GR ;
O'Sullivan, K ;
McCarter, R ;
Bunnage, M ;
Brooks, DJ ;
Svendsen, CN ;
Heywood, P .
NATURE MEDICINE, 2003, 9 (05) :589-595
[9]   Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance [J].
Grayson, ACR ;
Cima, MJ ;
Langer, R .
BIOMATERIALS, 2005, 26 (14) :2137-2145
[10]   Comparison of 14C-sucrose delivery to the brain by intravenous, intraventricular, and convection-enhanced intracerebral infusion [J].
Groothuis, DR ;
Ward, S ;
Itskovich, AC ;
Dobrescu, C ;
Allen, CV ;
Dills, C ;
Levy, RM .
JOURNAL OF NEUROSURGERY, 1999, 90 (02) :321-331